(Q45998531)

18 December 2017

title

Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. (English)

1 reference

18 December 2017

1 reference

Banker AS

1

1 reference

18 December 2017

Freeman WR

2

1 reference

18 December 2017

Kim JW

3

1 reference

18 December 2017

Munguia D

4

1 reference

18 December 2017

Azen SP

5

1 reference

18 December 2017

publication date

1 September 1997

1 reference

18 December 2017

published in

Ophthalmology

1 reference

18 December 2017

volume

104

1 reference

18 December 2017

issue

9

1 reference

18 December 2017

page(s)

1442-52; discussion 1452-3

1 reference

18 December 2017

Idiopathic senile macular hole. Its early stages and pathogenesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Observations concerning patients with suspected impending macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Reappraisal of biomicroscopic classification of stages of development of a macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitreous surgery for idiopathic macular holes. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitreous surgery for macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Retinal pigment epitheliopathy after macular hole surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Retinal pigment epitheliopathy after macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Retinal pigment epithelial abnormalities after macular hole surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Removal of epimacular membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Posterior segment complications after vitrectomy for macular hole

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitrectomy surgery for full-thickness macular holes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitreous surgery for macular hole in perspective. Is there an indication?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Visual field loss after macular hole surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

Vitrectomy for macular pucker.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930118-3

7 January 2021

10.1016/S0161-6420(97)30118-3

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017